Novartis begins shipment of Fluvirin®
15 July 2011 | By Novartis
Novartis announced that the Company has started shipping seasonal influenza vaccine to its US customers for the 2011-2012 influenza season...
List view / Grid view
News
Janssen Pharmaceuticals, Inc. announces definitive agreement to divest Ortho Dermatologics Division
15 July 2011 | By Janssen Pharmaceuticals Inc
Janssen Pharmaceuticals, Inc. announced a definitive agreement to divest the assets of its Ortho Dermatologics division...
Pertuzumab combined with Herceptin and chemotherapy significantly extended the time people with HER2-positive metastatic breast cancer lived without their disease getting worse
15 July 2011 | By Roche
Roche plans to seek approval with Health Authorities based on encouraging results...
ICON acquires Firecrest Clinical
14 July 2011 | By ICON plc
ICON plc, announced the acquisition of Firecrest Clinical, a market-leading provider of technology solutions that boost investigator site performance and study management...
Cephalon shareholders approve acquisition by Teva
14 July 2011 | By Cephalon Inc.
Cephalon, Inc. announced that its stockholders voted to approve the TEVA proposal to acquire Cephalon...
Novo Nordisk gains EU approval for FlexTouch®
14 July 2011 | By Novo Nordisk
Novo Nordisk has been granted approval by the European Commission for the new prefilled insulin pen – FlexTouch®...
YERVOY™ (ipilimumab) approved for the treatment of previously-treated advanced melanoma in the EU
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
Gilead expands access program for medications in developing world
12 July 2011 | By Gilead Sciences
Gilead Sciences, Inc. announced an expansion of its global access program...
Sanofi and Regeneron report positive Phase 2b trial results with sarilumab in rheumatoid arthritis
12 July 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials...
Clavis Pharma appoints Nicholas Adams as Chief Business Officer
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
Lilly CEO says biopharmaceuticals should be included in transatlantic trade and economic discussions
11 July 2011 | By Eli Lilly and Company
Biopharmaceuticals be included in transatlantic trade and economic discussions...
Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
Sanofi Divests Dermik Dermatology Unit to Valeant
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
Sanofi provides Multaq® Phase IIIb PALLAS trial update
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
